TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31146544

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg monthly
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg monthly (initial dosage)
Number of subjects: 383
Study: 28582403

Group type: EXPERIMENTAL
Intervention: Cholecalcipherol (300,000 IU) combined with standard treatment (methotrexate and glucocorticoids)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard treatment (methotrexate and glucocorticoids) without cholecalcipherol
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: eRA patients
Number of subjects: 39
Study: 23855643

Group type: EXPERIMENTAL
Intervention: Antibiotic regimen (pre- and post-operative)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 23454858

Group type: EXPERIMENTAL
Intervention: Internal fixation of the medial malleolus
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonoperative treatment of the medial malleolus
Number of subjects: 100
Study: 21626320

Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional ligature
Number of subjects: 23
Study: 19369574

Group type: EXPERIMENTAL
Intervention: High-purine meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-purine meal
Number of subjects: 20
Study: 16764619

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian drilling (LOD) plus 1700 mg per day of metformin for 6 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Laparoscopic ovarian drilling (LOD) alone
Number of subjects: 42
Study: 15233705

Group type: EXPERIMENTAL
Intervention: Asimadoline 0.5 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12240757

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Videobronchoscopy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Endotracheal tube sizing
Number of subjects: 10
Study: 9524516

Group type: EXPERIMENTAL
Intervention: Biodegradable tension-band fixation (B)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Metallic tension-band fixation (M)
Number of subjects: 38
Study: 7644080

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan 100 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 2758733

Group type: EXPERIMENTAL
Intervention: Intermittent infusion of cimetidine (300 mg every 6 hours)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cimetidine (37.5 mg per hour with a priming dose of 300 mg for 15 minutes)
Number of subjects: 26
Study: 792850

Group type: EXPERIMENTAL
Intervention: Antilymphocyte globulin (ALG) in addition to prednisone and azathioprine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 30
Study: 28776062

Group type: EXPERIMENTAL
Intervention: Mindfulness practice (20-min sessions weekly for one academic semester)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no mindfulness practice)
Number of subjects: 0
Study: 25871786

Group type: EXPERIMENTAL
Intervention: CASUS® group (using online cases for preparation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Book group (using a textbook)
Number of subjects: 0
Study: 22066521

Group type: EXPERIMENTAL
Intervention: Helping HAND intervention group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (regular paediatric care)
Number of subjects: 40
Study: 21967363

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Valproate (VPA)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1500
Study: 19386814

Group type: EXPERIMENTAL
Intervention: Remote ischaemic pre-conditioning (RIPC)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 17786601

Group type: EXPERIMENTAL
Intervention: Laser pointer used in group B to improve targeting capabilities of the cameras.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard navigated TKR without laser pointer in group A.
Number of subjects: 40
Study: 15284269

Group type: EXPERIMENTAL
Intervention: M-R catheters (minocycline and rifampin)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Nonimpregnated catheters
Number of subjects: 356
Study: 11157316

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 56
Study: 9022872

Group type: EXPERIMENTAL
Intervention: Caffeine use
Number of subjects: 162

Group type: COMPARATOR
Intervention: Caffeine abstinence
Number of subjects: 162
Study: 7884021

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 113
Study: 30502311

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment (no noninvasive ventilation)
Number of subjects: 40
Study: 28859383

Group type: EXPERIMENTAL
Intervention: Sodium alginate (10 mL of Gaviscon Advance)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Water (10 mL)
Number of subjects: 50
Study: 25847503

Group type: EXPERIMENTAL
Intervention: Topical autologous platelet-rich gel (APG) plus standard treatment
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Topical APG application
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Long-term survival and recurrence rates
Number of subjects: 117
Study: 24080677

Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cognitive Behavioral Group Therapy
Number of subjects: 32
Study: 21422207

Group type: EXPERIMENTAL
Intervention: Voriconazole 300 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Voriconazole 200 mg
Number of subjects: 8
Study: 18795972

Group type: EXPERIMENTAL
Intervention: Untreated hypertensive patients
Number of subjects: 1419
Study: 16874214

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 30
Study: 12909380

Group type: EXPERIMENTAL
Intervention: CC-CPR training (n=36)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Traditional CPR training (n=38)
Number of subjects: 74
Study: 10877011

Group type: COMPARATOR
Intervention: Caffeine 300 mg single oral dose in healthy controls
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 300 mg single oral dose in malaria patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 300 mg single oral dose in both groups
Number of subjects: 20
Study: 10437215

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture and routine treatment (Group 1, n = 29)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Routine treatment alone (Group 2, n = 30)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (non-ICVD, n = 38)
Number of subjects: 59
Study: 8259875

Group type: EXPERIMENTAL
Intervention: Recombinant interferon alfa-2a (INF-alpha-2a) 50,000 IU/kg/day
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 2951819

Group type: EXPERIMENTAL
Intervention: Duovent (ipratropium bromide 40 micrograms and fenoterol 100 micrograms)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Berodual (ipratropium bromide 20 micrograms and fenoterol 50 micrograms)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 21
Study: 30549489

Group type: EXPERIMENTAL
Intervention: NAC + aspirin (1,000 mg each)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: NAC (1,000 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Aspirin (1,000 mg)
Number of subjects: 24
Study: 26607938

Group type: EXPERIMENTAL
Intervention: Dietary nitrate (nitrate-rich beetroot juice)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (nitrate-depleted beetroot juice)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Dietary nitrate
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 24703391

Group type: EXPERIMENTAL
Intervention: Intra-articular polynucleotides (Condrotide)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Hyaluronic acid (Hyalubrix)
Number of subjects: 72
Study: 22145767

Group type: EXPERIMENTAL
Intervention: Collagen matrix (CM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 20398037

Group type: EXPERIMENTAL
Intervention: MK-0429 200 mg b.i.d.
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: MK-0429 1600 mg b.i.d.
Number of subjects: 21
Study: 17631461

Group type: EXPERIMENTAL
Intervention: Real Acupuncture (RA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham Acupuncture (SA)
Number of subjects: 18
Study: 15652165

Group type: EXPERIMENTAL
Intervention: Ketac Silver Aplicap (KSA)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Rebilda SC (RSC)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Rebilda D (RD)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Students
Number of subjects: 187

Group type: COMPARATOR
Intervention: Dentists
Number of subjects: 187
Study: 12085141

Group type: EXPERIMENTAL
Intervention: 90 degrees anterior fundoplication
Number of subjects: 83
Study: 10442881

Group type: EXPERIMENTAL
Intervention: Congenitally blind participants
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sighted participants (including blindfolded)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Blind and sighted children who gestured
Number of subjects: 36
Study: 7877098

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (no pravastatin)
Number of subjects: 109
Study: 2193045

Group type: EXPERIMENTAL
Intervention: Education programme (information booklet and demonstration)
Number of subjects: 45
Study: 646625

Group type: EXPERIMENTAL
Intervention: Dinitrochlorobenzene
Number of subjects: 23

Group type: COMPARATOR
Intervention: 5-Fluorouracil
Number of subjects: 23
Study: 31470912

Group type: EXPERIMENTAL
Intervention: Intersectoral care management
Number of subjects: 398

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 398
Study: 28315568

Group type: EXPERIMENTAL
Intervention: Normal tension glaucoma (NTG)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Primary open angle glaucoma (POAG)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Healthy subjects (Control)
Number of subjects: 129
Study: 26501862

Group type: EXPERIMENTAL
Intervention: Video interpretation
Number of subjects: 208

Group type: COMPARATOR
Intervention: Telephone interpretation
Number of subjects: 208
Study: 23343466

Group type: EXPERIMENTAL
Intervention: Antibacterial hand cleanser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glove occlusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Antibacterial hand cleanser + Glove occlusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pre-exposure cream
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Post-exposure cream
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pre-exposure cream + Post-exposure cream
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sodium lauryl sulfate (SLS)
Number of subjects: 20
Study: 21614939

Group type: EXPERIMENTAL
Intervention: Integrative medicine approach (six group sessions on nutritional manipulation, yoga techniques, journaling, plus nutritional supplements: fish oil, vitamin C, standardized hops extract)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Integrative medicine approach
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 154
Study: 19548250

Group type: EXPERIMENTAL
Intervention: CAMHS outpatient treatment
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Specialist outpatient treatment
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Support for parents from professionals and other parents
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Sibling support
Number of subjects: 215

Group type: COMPARATOR
Intervention: Generic CAMHS services
Number of subjects: 215
Study: 16991107

Group type: EXPERIMENTAL
Intervention: Audio‐taped‐‐patient given audiotape
Number of subjects: 425

Group type: COMPARATOR
Intervention: Standard care control‐‐not audio‐taped
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Audio‐taped‐‐no audiotape given
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Audio‐taped‐‐patient offered choice of receiving audiotape or not
Number of subjects: 425
Study: 15320690

Group type: EXPERIMENTAL
Intervention: Deceleration component (rapid deceleration to a stop within 6 m of the end of each sprint)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No deceleration zone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Deceleration component (hypothetical extrapolation)
Number of subjects: 18
Study: 11093063

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 171

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 171
Study: 9485979

Group type: EXPERIMENTAL
Intervention: Pre-operative administration of bupivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Postoperative administration of bupivacaine
Number of subjects: 80
Study: 8379174

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) retrograde injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study: 3729020

Group type: EXPERIMENTAL
Intervention: Lidocaine infiltration
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine infiltration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infiltration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline with epinephrine infiltration
Number of subjects: 8
Study: 30839100

Group type: EXPERIMENTAL
Intervention: Cycle-Specific Risk of Febrile Neutropenia after Chemotherapy score (CSRFENCE score)
Number of subjects: 4590

Group type: EXPERIMENTAL
Intervention: CSRFENCE score
Number of subjects: 4590
Study: 31671290

Group type: EXPERIMENTAL
Intervention: Hysteroscopic myomectomy with MyoSure® morcellator
Number of subjects: 320
Study: 30373778

Group type: EXPERIMENTAL
Intervention: Stepped-care intervention to prevent major depressive disorder (MDD)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Predictors of incident depression
Number of subjects: 236
Study: 27144850

Group type: EXPERIMENTAL
Intervention: Ozanimod 1 mg
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Ozanimod 0.5 mg
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 24474034

Group type: EXPERIMENTAL
Intervention: E2/LNG Low TDS (4.4 mg E2 and 1.39 mg LNG)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: E2/LNG High TDS (4.4 mg E2 and 2.75 mg LNG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: E2 0.050 mg/24 hours TDS and 0.090 mg LNG oral tablet
Number of subjects: 68
Study: 22676628

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group intervention before IVF and ICSI procedures
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (no psychological intervention)
Number of subjects: 188
Study: 20660689

Group type: EXPERIMENTAL
Intervention: Nemonoxacin 750 mg
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Nemonoxacin 500 mg
Number of subjects: 265

Group type: COMPARATOR
Intervention: Levofloxacin 500 mg
Number of subjects: 265
Study: 17685683

Group type: EXPERIMENTAL
Intervention: Contrast Water Therapy (CWT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Passive Recovery (PAS)
Number of subjects: 13
Study: 15638905

Group type: EXPERIMENTAL
Intervention: Doxazosin extended-release (XL) 4 or 8 mg once daily for 13 weeks
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Doxazosin standard 1-8 mg once daily for 13 weeks
Number of subjects: 680

Group type: COMPARATOR
Intervention: Control group (placebo run-in period)
Number of subjects: 680
Study: 11942178

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant treatment (chemotherapy, radiotherapy, multimodal treatments)
Number of subjects: 0
Study: 10091516

Group type: EXPERIMENTAL
Intervention: Home intravenous antibiotic therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Hospital intravenous antibiotic therapy
Number of subjects: 14
Study: 7589048

Group type: EXPERIMENTAL
Intervention: Piroxicam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2082837

Group type: EXPERIMENTAL
Intervention: Hypnotically induced analgesia
Number of subjects: 10
Study: 368044

Group type: EXPERIMENTAL
Intervention: Trebenzomine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Doxepin
Number of subjects: 26
Study: 31924257

Group type: EXPERIMENTAL
Intervention: Phase-change material based temperature-control liners for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular gel or silicone liners for 6 months
Number of subjects: 0
Study: 31112620

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice/day
Number of subjects: 110

Group type: COMPARATOR
Intervention: Lower than recommended dosing of apixaban
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice/day
Number of subjects: 110

Group type: COMPARATOR
Intervention: Recommended dosing of 5 mg twice/day
Number of subjects: 110
Study: 27430990

Group type: EXPERIMENTAL
Intervention: Bupivacaine lozenge (25 mg) administered as single dose to HNC patients with oral mucositis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bupivacaine lozenge (25 mg) administered as multiple doses to HNC patients with oral mucositis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bupivacaine lozenge (5, 10, 25, and 50 mg) administered as single dose to healthy individuals
Number of subjects: 25
Study: 26237979

Group type: EXPERIMENTAL
Intervention: Slow-rapid reinforcing-reducing needling manipulation at Jiaji (EX-B 2) acupoint
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uniform reinforcing-reducing manipulation at various acupoints
Number of subjects: 60
Study: 24252803

Group type: EXPERIMENTAL
Intervention: Auditory cueing during treadmill walking
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Non-cued treadmill walking
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cued treadmill walking
Number of subjects: 20
Study: 21848780

Group type: EXPERIMENTAL
Intervention: Educational programme on disaster preparedness for pregnant women
Number of subjects: 488

Group type: COMPARATOR
Intervention: Control group (no educational programme)
Number of subjects: 488
Study: 18563473

Group type: EXPERIMENTAL
Intervention: Parent training (PT)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Parent training combined with child therapy (PT + CT)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 127
Study: 17274807

Group type: EXPERIMENTAL
Intervention: Enhanced Relapse Prevention (ERP) training for care coordinators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 15178928

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 130

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 130
Study: 11878518

Group type: EXPERIMENTAL
Intervention: 0.4 MAC nitrous oxide (n=9)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.4 MAC isoflurane (n=9)
Number of subjects: 18
Study: 9633757

Group type: EXPERIMENTAL
Intervention: 2,000 IU vitamin E orally per day
Number of subjects: 0
Study: 7523775

Group type: EXPERIMENTAL
Intervention: 10 mg estradiol valerate
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 6363985

Group type: EXPERIMENTAL
Intervention: tiropramide hydrochloride (300 mg daily for 30 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: octylonium bromide (120 mg daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: tiropramide hydrochloride
Number of subjects: 60
Study: 30694699

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Both AE and RE
Number of subjects: 55
Study: 30014816

Group type: EXPERIMENTAL
Intervention: Bites from five NF135.C10-infected mosquitoes
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bites from one or two NF135.C10-infected mosquitoes
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bites from five NF166.C8-infected mosquitoes
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bites from one or two NF166.C8-infected mosquitoes
Number of subjects: 24
Study: 27049275

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate micro air pump suction
Number of subjects: 96

Group type: COMPARATOR
Intervention: Intravenous drip of magnesium sulfate
Number of subjects: 96
Study: 24917905

Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 22350328

Group type: EXPERIMENTAL
Intervention: Mentha crispa (24 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Secnidazole (2,000 mg)
Number of subjects: 60
Study: 20473047

Group type: EXPERIMENTAL
Intervention: SEMGAS biofeedback training plus functional restoration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Functional restoration only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal, pain-free participants)
Number of subjects: 0
Study: 17381122

Group type: EXPERIMENTAL
Intervention: Dried cranberry juice (DCJ) 1200 mg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dried cranberry juice (DCJ) 400 mg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Urine samples from DCJ consumption
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Metabolites identified from DCJ consumption
Number of subjects: 65
Study: 17852978

Group type: EXPERIMENTAL
Intervention: Individual lifestyle counselling
Number of subjects: 176

Group type: COMPARATOR
Intervention: Group-based counselling
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Both groups (Individual and Group-based counselling)
Number of subjects: 176